Sodium Bicarbonate Injection USP, 8.4% is supplied as 25 vials per tray in the following dosage form.
NDC No. (Unit of Sale) | 0409-6625-14 |
NDC No. (Each) | 0409-6625-22 |
Dosage Form | Flip Top Vial |
Conc. % | 8.4 |
mg/mL (NaHCO3) | 84 |
mEq/mL (Na+) | 1 |
mEq/mL (HCO3¯) | 1 |
mEq/Container Size (mL) | 50/50 |
mOsmol/mL | 1.56 |
Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. Protect from freezing. Store at 20°C to 25°C (68°F to 77°F). [See USP Controlled Room Temperature.]
Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
LAB-1158-4.0
Revised: 03/2025
{{section_name_patient}}
{{section_body_html_patient}}
Additional Resources
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine or vaccine.
Speak with a Pfizer Medical Information Professional regarding your Pfizer medicine or vaccine inquiry.
Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for a Pfizer medicine or a vaccine.
The submission will be reviewed during our standard business hours.
To report an adverse event related to a Pfizer product and you are not part of a clinical trial* for this medication, click the link below to submit your information:
Pfizer Safety Reporting Site
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website to report an adverse event related to a Pfizer medication, please call (800) 438-1985.
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or by calling (800) 332-1088.